Osiris Therapeutics Inc (OSIR):企業の財務・戦略的SWOT分析

◆英語タイトル:Osiris Therapeutics Inc (OSIR) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0973
◆発行会社(調査会社):GlobalData
◆発行日:2020年1月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Osiris Therapeutics Inc (OSIR) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Osiris Therapeutics Inc (Osiris) is a regenerative medicine company. It researches, develops and markets regenerative medicine products. The company developed the world’s first approved stem cell drug. It offers products in wound care, orthopedics, and sports medicine market. Osiris develops products based on BioSmart, a proprietary process for tissue and cell preservation that maintains integrity of the biological materials. Osiris, Grafix, Stravix and Cartiform are trademarks of Osiris. The company continues to advance its research and development (R&D) in biotechnology by focusing on innovation in regenerative medicine including stem cell research, bioengineering and viable tissue based products. Osiris is headquartered in Columbia, Maryland, the US.

Osiris Therapeutics Inc Key Recent Developments

Mar 13,2019: Smith & Nephew to buy Osiris Therapeutics in $660m deal

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Osiris Therapeutics Inc – Key Facts
Osiris Therapeutics Inc – Key Employees
Osiris Therapeutics Inc – Key Employee Biographies
Osiris Therapeutics Inc – Major Products and Services
Osiris Therapeutics Inc – History
Osiris Therapeutics Inc – Company Statement
Osiris Therapeutics Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Osiris Therapeutics Inc – Business Description
Osiris Therapeutics Inc – Corporate Strategy
Osiris Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Osiris Therapeutics Inc – Strengths
Osiris Therapeutics Inc – Weaknesses
Osiris Therapeutics Inc – Opportunities
Osiris Therapeutics Inc – Threats
Osiris Therapeutics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Osiris Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 13, 2019: Smith & Nephew to buy Osiris Therapeutics in $660m deal
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Osiris Therapeutics Inc, Key Facts
Osiris Therapeutics Inc, Key Employees
Osiris Therapeutics Inc, Key Employee Biographies
Osiris Therapeutics Inc, Major Products and Services
Osiris Therapeutics Inc, History
Osiris Therapeutics Inc, Subsidiaries
Osiris Therapeutics Inc, Key Competitors
Osiris Therapeutics Inc, Ratios based on current share price
Osiris Therapeutics Inc, Annual Ratios
Osiris Therapeutics Inc, Annual Ratios (Cont...1)
Osiris Therapeutics Inc, Interim Ratios
Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Osiris Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Osiris Therapeutics Inc, Performance Chart (2014 - 2018)
Osiris Therapeutics Inc, Ratio Charts
Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Osiris Therapeutics Inc (OSIR):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Armour Residential REIT, Inc.:企業のM&A・事業提携・投資動向
    Armour Residential REIT, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Armour Residential REIT, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Ur-Energy Inc. (URE):企業の財務・戦略的SWOT分析
    Ur-Energy Inc. (URE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Societe BIC (BB):企業の財務・戦略的SWOT分析
    Societe BIC (BB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Verona Pharma Plc (VRP):医療機器:M&Aディール及び事業提携情報
    Summary Verona Pharma Plc (Verona Pharma) is a clinical-stage biotechnology company, which focuses on the research, discovery and development of first-in-class therapeutic drugs for the treatment of chronic respiratory and inflammatory diseases. The company's lead candidate, RPL554 is a bronchodilat …
  • TIS Inc (3626):企業の財務・戦略的SWOT分析
    TIS Inc (3626) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • San Juan Basin Royalty Trust (SJT):企業の財務・戦略的SWOT分析
    Summary San Juan Basin Royalty Trust (SJT) operates as a trust that has overriding royalty interest divided out of Southland Royalty's oil and gas leasehold and royalty interest in the San Juan Basin of northwestern New Mexico. The trust’s underlying properties include royalty interests, overriding …
  • Einstein Noah Restaurant Group, Inc. (Foodservice):企業の戦略・SWOT・財務情報
    Einstein Noah Restaurant Group, Inc. (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary Einstein Noah Restaurant Group, Inc. (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's struct …
  • IXYS, LLC:企業の戦略的SWOT分析
    IXYS, LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Siemens Gamesa Renewable Energy SA (SGRE):企業の財務・戦略的SWOT分析
    Siemens Gamesa Renewable Energy SA (SGRE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • hVIVO Plc (HVO):企業の財務・戦略的SWOT分析
    Summary hVIVO Plc (hVIVO), formerly Retroscreen Virology Ltd is a biopharma company that develops human-based analytical platform to accelerate drug discovery and development. The company enables organisations to discover drugs and diagnostics and accelerate new product development. It uses human di …
  • Tennessee Valley Authority:企業の戦略的SWOT分析
    Tennessee Valley Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Global Blood Therapeutics Inc (GBT):製薬・医療:M&Aディール及び事業提携情報
    Summary Global Blood Therapeutics Inc (GBT) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes novel oral medicines for the treatment of grievous blood-based disorders. The company's lead drug candidate GBT440 is an oral, small molecule drug for the treatment o …
  • Old Dominion Electric Cooperative:企業の戦略的SWOT分析
    Old Dominion Electric Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Pratt & Whitney Canada Corp.:企業の戦略・SWOT・財務情報
    Pratt & Whitney Canada Corp. - Strategy, SWOT and Corporate Finance Report Summary Pratt & Whitney Canada Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Ford Motor Company:戦略・SWOT・企業財務分析
    Ford Motor Company - Strategy, SWOT and Corporate Finance Report Summary Ford Motor Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Invenergy LLC:企業の戦略的SWOT分析
    Invenergy LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Infinera Corporation:戦略・SWOT・企業財務分析
    Infinera Corporation - Strategy, SWOT and Corporate Finance Report Summary Infinera Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • TrueBlue Inc (TBI):企業の財務・戦略的SWOT分析
    Summary TrueBlue Inc (TrueBlue) is a talent solution company that provides filling individual positions on demand, staffing entire facilities and managing outsourced recruiting processes and staffing vendor programs. The company business division includes People Ready, Workforce Management and Peopl …
  • MEDITE Cancer Diagnostics Inc (MDIT):企業の財務・戦略的SWOT分析
    MEDITE Cancer Diagnostics Inc (MDIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Program for Appropriate Technology in Health-製薬・医療分野:企業M&A・提携分析
    Summary Program for Appropriate Technology in Health (PATH) is a healthcare organization that offers vaccines, drugs, diagnostics, devices, system and service innovations, and digital health solutions. The organization offers HIV and AIDS, influenza, malaria and tuberculosis care services. It develo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆